When we compared CSF-GFAP levels in different types of alpha-synucleinopathies, our obtained data indicated elevated GFAP levels in patients with MSA compared with PD (p < 0.05) (Figure 1C). The gene discussed is GFAP; the disease is multiple system atrophy.